Sentinel Lymph Node Based Management or Routine Axillary Clearance? Three-year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial

Annals of Surgical Oncology

Volumn 22, Issue 1, 2015, Pages 17-23

  Wetzig, Neil ^a   Gill, Peter Grantley ^b   Zannino, Diana ^c   Stockler, Martin R ^c,d   Gebski, Val ^c   Ung, Owen ^e   Campbell, Ian ^f   Simes, R John ^c  

^a WESLEY HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f WAIKATO HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARM MOVEMENT; ARM SWELLING; ARTICLE; BREAST CANCER; CANCER SURGERY; CONTROLLED STUDY; DISABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; ROUTINE AXILLARY CLEARANCE; SENTINEL LYMPH NODE BIOPSY; SENTINEL NODE BASED MANAGEMENT; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; ADULT; AXILLA; BREAST NEOPLASMS; CANCER STAGING; COMPARATIVE STUDY; DISEASE MANAGEMENT; LYMPH NODE; LYMPH NODE DISSECTION; MASTECTOMY; PATHOLOGY; PROGNOSIS;

ADULT; AXILLA; BREAST NEOPLASMS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MASTECTOMY; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 84919731583     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3928-7     Document Type: Article

References (12)

1. Gill PG, Wetzig N, Gebski V, et al; SNAC Trial Group. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol. 2009;16:266–75.
2. Tewari N, Gill PG, Bochner M, Kollias J. Comparison of volume displacement versus circumferential upper limb measurements for lymphoedema: implications for the SNAC trial. ANZ J Surg. 2008;78:889–93.
3. Smith MJ, Gill PG, Wetzig N, et al; Royal Australasian College of Surgeons SNAC Trial Group. Comparing patients’ and clinicians’ assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial). Breast Cancer Res Treat. 2009;117:99–109.
4. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93:96–111.
5. Kell MR, Burke JP, Barry M, Morrow M. Outcome of axillary staging in early breast cancer: a meta-analysis. Breast Cancer Res Treat. 2010;120:441–7.
6. Land SR, Kopec JA, Julian TB, et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: national surgical adjuvant breast and bowel project phase III protocol B-32. J Clin Oncol. 2010;28:3929–36.
7. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.
8. Krag D, Anderson SJ, Julian TB, et all. Sentinel lymph node resection compared with conventional axillary lymph node dissectionin clinically node negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.
9. Fleissig A, Fallowfield L, Langridge CI, et al. Post-operative upper limb morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary dissection in management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279–93.
10. Haddad P, Farzin M, Amouzegar-Hashemi F, et al. A multicentre cross-sectional study of arm lymphedema four or more years after breast cancer treatment in Iranian patients. Breast Cancer. 2010;17:281–5.
11. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.
12. Goyal A, Newcombe RG, Chhabra A, Mansel RE. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol. 2008;15:262–7.